arginine has been researched along with Cardiotoxicity in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Yalta, K; Yalta, T; Yetkin, E | 1 |
| Abdel-Magied, N; Shedid, SM | 1 |
| Gusachenko, I; Lymanets, T; Maslova, G; Skrypnyk, I | 2 |
| Anastasiou, M; Antonopoulos, AS; Bamias, A; Dimopoulos, MA; Oikonomou, E; Psaltopoulou, T; Siasos, G; Tousoulis, D; Zagouri, F | 1 |
| Arcari, A; Centurioni, R; Evangelista, A; Freilone, R; Ladetto, M; Liberati, AM; Luminari, S; Massidda, S; Merli, F; Musuraca, G; Nassi, L; Patti, C; Pavone, V; Peli, A; Pulsoni, A; Re, A; Salvi, F; Spina, M; Stelitano, C; Tani, M; Tucci, A; Volpetti, S; Zanni, M | 1 |
2 trial(s) available for arginine and Cardiotoxicity
| Article | Year |
|---|---|
L-arginine is an effective medication for prevention of endothelial dysfunction, a predictor of anthracycline cardiotoxicity in patients with acute leukemia.
Topics: Adolescent; Adult; Anthracyclines; Antineoplastic Agents; Antioxidants; Arginine; Cardiotoxicity; Endothelium, Vascular; Female; Heart; Humans; Leukemia; Male; Middle Aged; Young Adult | 2017 |
Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL).
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Carmustine; Combined Modality Therapy; Female; Heart Diseases; Hodgkin Disease; Humans; Male; Methotrexate; Methylprednisolone; Neoplasm Staging; Prognosis; Recurrence; Remission Induction; Survival Analysis; Teniposide; Treatment Outcome | 2019 |
4 other study(ies) available for arginine and Cardiotoxicity
| Article | Year |
|---|---|
Serum Copeptin in Cardiooncology Practice: Review of Pathophysiological and Clinical Implications.
Topics: Antineoplastic Agents; Arginine; Biomarkers; Cardiotoxicity; Echocardiography; Glycopeptides; Heart Injuries; Humans; Neoplasms | 2023 |
Impact of zinc oxide nanoparticles on thioredoxin-interacting protein and asymmetric dimethylarginine as biochemical indicators of cardiovascular disorders in gamma-irradiated rats.
Topics: Animals; Arginine; Biomarkers; Cardiotoxicity; Cell Cycle Proteins; Cytokines; Dose-Response Relationship, Drug; Gamma Rays; Heart; Inflammation; Male; Nanoparticles; Oxidative Stress; Radiation Injuries, Experimental; Rats; Zinc Oxide | 2020 |
How to improve quality of life in patients with acute leukemia and comorbid ischemic heart disease treated with anthracycline-based induction chemotherapy.
Topics: Adult; Anthracyclines; Antibiotics, Antineoplastic; Arginine; Cardiotoxicity; Comorbidity; Cryoprotective Agents; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Myocardial Ischemia; Quality of Life | 2019 |
Flow-Mediated Dilation of Brachial Artery as a Screening Tool for Anthracycline-Induced Cardiotoxicity.
Topics: Anthracyclines; Arginine; Brachial Artery; Breast Neoplasms; Cardiotoxicity; Dilatation; Early Detection of Cancer; Heart Diseases; Humans; Nitric Oxide | 2017 |